Starbucks denies that its decision to stop selling Chicken, Maple Butter, and Egg Sandwich on June 26, a mere five days after it had been announced as a new permanent menu item, was due to FDA recall or salmonella or listeria contamination.
A Starbucks spokesperson said that the Chicken, Maple Butter, and Egg Sandwich was given a voluntary stop sell and discard order by the company because it didn't live up to the company's high standards for quality.
The quality issue that was identified by Starbucks was simply about taste or based on another issue and would not lead to food-borne illness and any reports linking the stop sale to illness are inaccurate.
The spokesperson added that Starbucks is devoted to providing high-quality products, and anytime a concern about a product or its quality is expressed, we always proceed with extreme caution.


Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
BoE Set to Cut Rates as UK Inflation Slows, but Further Easing Likely Limited
Debate over H-1B visas shines spotlight on US tech worker shortages
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Canada Signals Delay in US Tariff Deal as Talks Shift to USMCA Review 



